CHMP4C and TNF, as high-risk genes for tumor promotion, positively correlate with promoting tumor progression immune-related cells such as activated mast cells and resting dendritic cells, and negatively correlate with protective immune-related cells such as naïve B cells and CD8+ T cells. The gene discussed is TNF; the disease is neoplasm.